TLRY
TLRY
NASDAQ · Pharmaceuticals

Tilray Brands Inc

$2.81
-0.15 (-5.07%)
As of Nov 7, 1:55 AM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 8 47%
Hold 9 53%
Sell 0 0%
Price Target
Analyst Price Target +1,406.0% upside
Low Target $27.22
Average Target $42.32
High Target $56.32
Current Price $2.81
Current
$2.81
Target
$42.32
$27.22 $42.32 avg $56.32
Scenario Analysis
Bear Case
$27.22
868.7%
Low target
Base Case
$42.32
+1,406.0%
Avg target
Bull Case
$56.32
+1,904.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$15.70
-82.1% from high
52-Week Low
$2.49
+13.1% from low
Target vs 52W High
$42.32
+169.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%